These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 26384060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF, Javed I, Shuja S, Shoaib T, Bano K, Waheed S, Ansar A.
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of mifepristone and misoprostol in second trimester pregnancy termination.
    Joensuu-Manninen H, Kuvaja P, Talvensaari-Mattila A.
    Acta Obstet Gynecol Scand; 2010 Dec; 89(12):1552-6. PubMed ID: 21080899
    [Abstract] [Full Text] [Related]

  • 5. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y, Chanrachakul B, Punyavachira P.
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [Abstract] [Full Text] [Related]

  • 6. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
    Kapp N, Todd CS, Yadgarova KT, Alibayeva G, Nazarova D, Loza O, Babadjanova GS.
    Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
    [Abstract] [Full Text] [Related]

  • 7. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S, Fekih M, Chaïeb A, Bibi M, Mellouli R, Khaïri H.
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [Abstract] [Full Text] [Related]

  • 8. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE, Brownell P, McGinnis K, Nathan EA.
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [Abstract] [Full Text] [Related]

  • 9. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy.
    Zangeneh M, Malek-Khosravi S, Veisi F, Rezavand N, Rezaee M, Rajatee M.
    Int J Gynaecol Obstet; 2012 Apr; 117(1):78-80. PubMed ID: 22261129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D, Deutsch M, Paz Y, Khatib N, Baltiter T, Rosenberg S, Lowenstein L.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [Abstract] [Full Text] [Related]

  • 12. Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality.
    Dickinson JE, Doherty DA.
    Prenat Diagn; 2009 May; 29(5):520-4. PubMed ID: 19235816
    [Abstract] [Full Text] [Related]

  • 13. Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section.
    Cayrac M, Faillie JL, Flandrin A, Boulot P.
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):145-9. PubMed ID: 21511389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination.
    Dickinson JE, Evans SF.
    Am J Obstet Gynecol; 2002 Mar; 186(3):470-4. PubMed ID: 11904609
    [Abstract] [Full Text] [Related]

  • 16. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S, Banerjee PK, Mundle M, Mitra SN.
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose vaginal misoprostol with or without Foley catheter for late second-trimester pregnancy termination in women with previous multiple cesarean sections.
    El Sharkwy IAE, Elsayed ML, Ahmed MA, Alnemer AAA.
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3703-3707. PubMed ID: 29742942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.